Phyllanthin

CAS No. 10351-88-9

Phyllanthin( —— )

Catalog No. M23242 CAS No. 10351-88-9

Phyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 129 In Stock
10MG 191 In Stock
25MG 322 In Stock
50MG 475 In Stock
100MG 680 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phyllanthin
  • Note
    Research use only, not for human use.
  • Brief Description
    Phyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.
  • Description
    Phyllanthin is widely used as hepatoprotective and antigenotoxic and inhibit function of P-gp.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10351-88-9
  • Formula Weight
    418.5
  • Molecular Formula
    C24H34O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (149.34 mM)
  • SMILES
    COC[C@@H](CC1=CC=C(OC)C(OC)=C1)[C@@H](COC)CC2=CC=C(OC)C(OC)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells.J Pharm Pharmacol. 2013 Feb;65(2):292-9.
molnova catalog
related products
  • Didox

    A ribonucleotide reductase inhibitor; overcomes Bcl-2 mediated radiation resistance in PC-3 cells.

  • OT-551 HCl

    OT-551 HCl is an NF-Κb inhibitor, a disubstituted hydroxylamine with antioxidant properties can be used for the treatment of cataracts and age-related macular degeneration and geographic atrophy (GA).

  • NF-κB-IN-1

    NF-κB-IN-1 is a potent NF-κB signaling pathway inhibitor. It is a 4-arylidene crucumin analogue. NF-κB-IN-1 directly inhibits IKK to block NF-κB activation.